Promising new cancer therapies are tested with the help of this clinical research organisation, which runs international drug trials on behalf of biopharmaceutical companies in Europe and North America. The Edinburgh firm, founded in 1999 by cancer specialist Clare Wareing, liaises with hospitals and oncology centres to set up and manage clinical trials. It has recently added new offices in America, Poland, Hungary and Scandinavia to service a growing volume of cancer research. Sales at Nexus Oncology have risen 52% a year from £1.6m in 2005 to £5.5m in 2008.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.